BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 9782074)

  • 1. Traditional processing increases biological activities of Dendrobium offificinale Kimura et. Migo in Southeast Yunnan, China.
    Zhou D; Zhao Y; Chen Z; Yan X; Zhao Y; Gao L; Yang L
    Sci Rep; 2022 Aug; 12(1):14814. PubMed ID: 36045147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
    Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM; Fouda FM; Ali EH; Motelp BA
    Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
    al-Shabanah OA; Badary OA; Nagi MN; al-Gharably NM; al-Rikabi AC; al-Bekairi AM
    J Exp Clin Cancer Res; 1998 Jun; 17(2):193-8. PubMed ID: 9700580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice.
    Wahab MH; Akoul ES; Abdel-Aziz AA
    Tumori; 2000; 86(2):157-62. PubMed ID: 10855855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.
    Warrington RC
    Biochem Cell Biol; 1992 May; 70(5):365-75. PubMed ID: 1353969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of anticancer agent activity by selective inhibition of rapidly proliferating tissues of the host.
    Stolfi RL; Martin DS
    Pharmacol Ther; 1991; 49(1-2):43-54. PubMed ID: 1712975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-histidinol on the antitumour activity and acute cardiotoxicity of doxorubicin in mice.
    Al-Shabanah OA; Badary OA; Al-Gharably NM; Al-Sawaf HA
    Pharmacol Res; 1998 Sep; 38(3):225-30. PubMed ID: 9782074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
    Warrington RC
    Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.